SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bafna Pharmaceuticals gets UK-MHRA approval for packaging lines

04 May 2021 Evaluate

Bafna Pharmaceuticals has added two fully automated packaging lines to its existing capacity and they have been approved by the UK-MHRA (Medicines and Healthcare products Regulatory Agency) for the United Kingdom and the European Union (EU). This approval will enable the company to increase its output and consequentially generate higher revenue and profits.

Bafna Pharmaceuticals is engaged in the business of manufacturing of finished pharmaceutical formulations.

Bafna Pharma Share Price

139.55 -5.45 (-3.76%)
13-Apr-2026 12:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.50
Dr. Reddys Lab 1228.75
Cipla 1212.55
Zydus Lifesciences 923.65
Lupin 2320.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×